Clinical Trial Update: Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update examining Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT imaging in the same group of prostate cancer patients across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-617
• Al18F-PSMA-617 (Al18F-PSMA-617)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: UNKNOWN